Skip to content
Home/Companies/Pharma/SERB Pharmaceuticals
SERB Pharmaceuticals

SERB Pharmaceuticals

Pharma·Europe·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns SERB Pharmaceuticals?

SERB Pharmaceuticals is a Pharma company based in Europe, currently owned by Merieux Equity Partners since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 3 · 2019 · Buyout

Key facts

HQEurope
SectorPharma
StatusActive
Websiteserb.com

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Exited 2025
PharmaFrance
to ARCHIMED
Janvier Labs
Janvier Labs
Active
HealthcareFrance· 2022
Dental Monitoring
Dental Monitoring
Active
HealthTechFrance· 2021
Domus VI
Domus VI
Active
HealthcareFrance· 2021
DomusVi
DomusVi
Active
HealthcareFrance· 2021
SWIXX BioPharma
SWIXX BioPharma
Exited 2026
PharmaSwitzerland· 2021
to SK Capital / Bain Capital Life Sciences

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns SERB Pharmaceuticals?

SERB Pharmaceuticals is currently owned by Merieux Equity Partners, through Mérieux Participations 3, since 2021.

When did Merieux Equity Partners acquire SERB Pharmaceuticals?

Merieux Equity Partners acquired SERB Pharmaceuticals in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue